Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
europe blog main
europe top stories
indiana blog main
indiana top stories
3
×
life sciences
national blog main
national top stories
novartis
san francisco blog main
san francisco top stories
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
deerfield management
detroit blog main
detroit top stories
fda
gilead sciences
ipo
melinta therapeutics
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
abbvie
What
medicines
3
×
bio
covid
fda
ipo
roundup
acquisitions
activity
address
announced
approval
approvals
approves
biogen
blueprint
cancer
carries
ceo
certain
clamped
collabs
daniel
deal
delays
designed
developing
drug
economic
fast
genetic
gilead
gilead’s
help
including
introduce
isn’t
latest
lot
month
new
Language
unset
Current search:
medicines
×
cancer
×
" indiana top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
